Company news
Gossamer Bio, Inc. news in 2021
Gossamer Bio, Inc.'s news releases, calls and decks from 2021, newest first.
Onxeo Continues to Strengthen its Board of Directors
November 22, 2021
Gossamer Bio Announces Third Quarter 2021 Financial Results and Provides Corporate Update
November 7, 2021
Gossamer Bio to Announce Third Quarter 2021 Financial Results and Host Conference Call and Webcast on November 8, 2021
November 1, 2021
Gossamer Bio Announces Addition of Two CNS-Penetrant BTK Inhibitors to its Product Candidate Pipeline: GB5121 & GB7208
October 10, 2021
Gossamer Bio to Host Webcast Announcing its Next Clinical Product Candidates on October 11, 2021
October 6, 2021
Gossamer Bio Announces Appointment of Bryan Giraudo as Chief Operating Officer, in addition to Chief Financial Officer Role
September 20, 2021
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
August 8, 2021
Gossamer Bio to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 9, 2021
August 1, 2021
Gossamer Bio Announces GB004 Clinical Trial Data Presentations at 2021 Virtual Congress of the European Crohn’s and Colitis Organisation
July 6, 2021
Gossamer Bio Announces Promotion of Richard Aranda, M.D., to Chief Medical Officer
June 20, 2021
Gossamer Bio Announces Appointment of Sandra Milligan, M.D., J.D., to its Board of Directors
June 13, 2021
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
May 5, 2021
Gossamer Bio Announces Executive Management Transition and Promotion of Laura Carter, Ph.D., to Chief Scientific Officer
April 19, 2021
Gossamer Bio Announces Promotion of Caryn Peterson to Executive Vice President, Regulatory Affairs
April 15, 2021
Gossamer Bio Announces Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Update
February 24, 2021
Gossamer Bio to Announce Fourth Quarter and Full-Year 2020 Financial Results and Host Conference Call and Webcast on February 25, 2021
February 18, 2021
Gossamer Bio to Host Webcast Focused on its Inflammatory Bowel Disease Program, GB004, on February 18, 2021
February 3, 2021
Calls in 2021
Decks in 2021
- ECCO'21 Virtual Congress (June 2021)
Conference · 8 slides · Jun 4, 2021